Video. Alzheimer's hope as new drug appears to reduce symptoms by a third
People in the early stages of Alzheimer’s who received infusions of donanemab in the 18-month trial showed 35 per cent less decline.
Read full article
Latest video
Understanding hake's remarkable recovery in the Atlantic
IN PARTNERSHIP WITH THE EUROPEAN COMMISSION
Interview: How Europe’s swift action saved commercial hake stocks
IN PARTNERSHIP WITH THE EUROPEAN COMMISSION
Japan is growing a nature-positive economy: here’s how
IN PARTNERSHIP WITH THE GOVERNMENT OF JAPAN
Watch: The inventor empowering schoolchildren with light in Zimbabwe
IN PARTNERSHIP WITH MEDIA CITY
